Drugs and the liver

Brodie, 1958, Enzymatic metabolism of drugs and other foreign compounds, Ann. Rev. Biochem., 27, 427, 10.1146/annurev.bi.27.070158.002235 1958, Drugs and liver disease, Brit. M. J., 2, 1149, 10.1136/bmj.2.5105.1149 Zimmerman, H. J.: Clinical and laboratory manifestations of hepatotoxicity, Ann. New York Acad. Sc. (to be published). References to the original reports could not be included in this abbreviated bibliography but will be supplied on request. Drill, 1952, Hepatotoxic agents: Mechanism of action and dietary interrelationship, Pharm. Rev., 4, 1 Drill, 1960, 38, 786 Klatskin, 1956, Toxic hepatitis, 328 Popper, 1959, Drug-induced hepatic injury, Ann. Int. Med., 51, 1230, 10.7326/0003-4819-51-6-1230 Himsworth, 1947 Arias, 1962, Effect of certain plant alkaloids and anabolic steroids in liver function Ducci, 1947, Contributions of laboratory to differential diagnosis of jaundice, J.A.M.A., 135, 694, 10.1001/jama.1947.02890110012004 Gutman, 1957, Drug reactions characterized by cholestasis associated with intrahepatic biliary tract obstruction, Am. J. Med., 23, 841, 10.1016/0002-9343(57)90293-0 Hanger, 1940, Postarsphenamine jaundice, J.A.M.A., 115, 263, 10.1001/jama.1940.02810300003002 Melrose, 1960, Drug-induced jaundice, Scot. M. J., 5, 250, 10.1177/003693306000500603 Simpson, 1960, Hypersensitivity due to paraaminosalicylic acid, Am. J. Med., 29, 297, 10.1016/0002-9343(60)90026-7 Hollister, 1957, Allergy to chlorpromazine manifested by jaundice, Am. J. Med., 23, 870, 10.1016/0002-9343(57)90296-6 Werther, 1957, Chlorpromazine jaundice, Am. J. Med., 22, 251, 10.1016/0002-9343(57)90091-8 Waitskin, 1960, Probable hepatic allergy to chlorpromazine and deliberate desensitization, Ann. Int. Med., 53, 115 Zelman, 1959, Liver cell necrosis in chlorpromazine jaundice (allergic cholangitis): Serial study of twenty-six needle biopsy specimens in nine patients, Am. J. Med., 27, 708, 10.1016/0002-9343(59)90188-3 Myers, 1957, Xanthomatous biliary cirrhosis following chlorpromazine, with observations indicating overproduction of cholesterol, hyperprothrombinemia, and the development of portal hypertension, Tr. A. Am. Physicians, 70, 243 Read, 1961, Chronic chlorpromazine jaundice with particular reference to its relationship to primary biliary cirrhosis, Am. J. Med., 31, 249, 10.1016/0002-9343(61)90113-9 Dickes, 1957, Serial liver-function and blood studies in patients receiving chlorpromazine, New England J. Med., 256, 1, 10.1056/NEJM195701032560101 Rosenblum, 1960, Hepatocellular jaundice as a complication of iproniazid therapy, A.M.A. Arch. Int. Med., 105, 583, 10.1001/archinte.1960.00270160081010 Hueper, 1948, Cinchopen (Atophan): A critical review, Medicine, 27, 43, 10.1097/00005792-194802000-00002 Engleman, 1954, Ingestion of phenylbutazone, J.A.M.A., 156, 97 Marble, 1957, Clinical experience with sulfonylurea compounds in diabetes, Ann. New York Acad. Sc., 71, 239, 10.1111/j.1749-6632.1957.tb54595.x McMahon, 1962, Comparative pharmacology of a variety of hypoglycemic drugs, Current Therapy Res., 4, 330 Foss, 1959, Oral methyltestosterone and jaundice, Brit. M. J., 1, 259, 10.1136/bmj.1.5117.259 Werner, 1950, Jaundice during methyl testosterone therapy, Am. J. Med., 8, 325, 10.1016/0002-9343(50)90065-9 Schaffner, 1960, Changes in bile canaliculi produced by norethandrolone: Electron microscopic study of human and rat liver, J. Lab. & Clin. Med., 56, 428 Kory, 1959, Six month evaluation of anabolic drug, norethandrolone, in underweight persons. II. Bromsulfalein (BSP) retention and liver function, Am. J. Med., 26, 243, 10.1016/0002-9343(59)90313-4 Marquardt, 1961, Effect of anabolic steroids on liver function tests and creatinine excretion, J.A.M.A., 175, 851, 10.1001/jama.1961.03040100015005 Perkins, 1962, Phenindione jaundice, Lancet, 1, 125, 10.1016/S0140-6736(62)91130-3 Selzer, 1951, Sennecio poisoning exhibiting as Chiari's syndrome: Report on 12 cases, Am. J. Path., 27, 885